Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
This grant offers funding for studies to evaluate the biological effects and effectiveness of potential treatments for neurological or neuromuscular disorders. The aim is to show that these treatments, which may include small molecules or biologics, are promising enough for further development. This grant is part of the IGNITE program, which helps early-stage projects advance to meet the requi…
This FOA provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological or neuromuscular disorders that fall under the NINDS miss…
Funding Source
Awards & funding
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers